María Natalia Gandur Quiroga

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  

María Natalia Gandur Quiroga
Feb 15, 2025, 14:31 | Blog
Highlights by María Natalia Gandur Quiroga from ASCO GU25
The 2025 ASCO Genitourinary (GU) Cancers Symposium takes place from February 13 to 15, featuring…
Feb 14, 2025, 20:30 | Societies
Highlights From Day 1 of ASCOGU25
The ASCO Genitourinary Cancers Symposium (ASCOGU25) is an annual event organized by the American Society…
Feb 9, 2025, 15:06 | Science
ctDNA: A game-changer in kidney cancer? 
María Natalia Gandur Quiroga, Medical Oncologist and Chief of the Division of Genitourinary Medical Oncology…
Feb 2, 2025, 01:42 | Insight
María Natalia Gandur Quiroga: Men’s Attitudes Towards Participation in Organised Prostate Cancer Testing
María Natalia Gandur Quiroga, Chief of the Division of Genitourinary Medical Oncology at the Angel…
Dec 22, 2024, 10:03 | Science
María Natalia Gandur Quiroga: Checkpoint inhibitors and Fc functions - key findings in oncology immunotherapy
María Natalia Gandur Quiroga, Chief of the Division of Genitourinary Medical Oncology at the Ángel…
Dec 18, 2024, 12:55 | Insight
María Natalia Gandur Quiroga: NECTIN4 Amplification Predicts Enfortumab Vedotin Response in mUC by Niklas Klümper et al.
María Natalia Gandur Quiroga, Medical Oncologist and Chief of the Division of Genitourinary Medical Oncology…
Dec 2, 2024, 09:04 | Blog
How can mpMRI change management of patients with NMIBC or MIBC?
María Natalia Gandur Quiroga, Medical Oncologist and Chief of the Division of Genitourinary Medical Oncology…
Dec 1, 2024, 16:04 | Insight
Highlights from PROSCA 2024 by María Natalia Gandur Quiroga
PROSCA 2024, the final part of the RENALC-BLADDR-PROSCA 2024 forum, took place on November 29…
Nov 29, 2024, 15:54 | Insight
Highlights from BLADDR 2024 by María Natalia Gandur Quiroga
BLADDR 2o24, Second session of the ongoing RENALC-BLADDR-PROSCA 2024 Hybrid Global Forum on GU Oncology,…
Nov 27, 2024, 16:55 | Insight
Highlights from RENALC 2024 by María Natalia Gandur Quiroga
RENALC 2o24, the opening session of the ongoing RENALC-BLADDR-PROSCA 2024 Hybrid Global Forum on GU…
Nov 27, 2024, 16:03 | Blog
María Natalia Gandur Quiroga: Case Discussion - Treatment Options for Metastatic pRCC
María Natalia Gandur Quiroga, Coordinator in charge of the Urological Clinical Service of the Angel…
Nov 12, 2024, 18:55 | Insight
María Natalia Gandur Quiroga: Just cast my vote for the ASCO election
María Natalia Gandur Quiroga, Coordinator in charge of the Urological Clinical Service of the Angel…
Nov 10, 2024, 19:03 | Blog
María Natalia Gandur Quiroga: Hallmarks of Cancer Immune Evasion by Claudia Galassi et al.
María Natalia Gandur Quiroga, Medical Oncologist and Chief of the Division of Genitourinary Medical Oncology at…
Nov 5, 2024, 17:26 | Blog
María Natalia Gandur Quiroga: Thrilled to be part of UroTarget 2024
María Natalia Gandur Quiroga, Medical Oncologist and Chief of the Division of Genitourinary Medical Oncology…
Nov 3, 2024, 09:22 | Blog
María Natalia Gandur Quiroga: Adjuvant Pembrolizumab in Muscle-Invasive Urothelial Carcinoma
María Natalia Gandur Quiroga posted on X: "AMBASSADOR Study: Adjuvant Pembrolizumab in Muscle-Invasive Urothelial Carcinoma…
Oct 20, 2024, 18:03 | Blog
María Natalia Gandur Quiroga: Early-Onset Cancers - Unraveling Biological Causes and Clinical Implications
María Natalia Gandur Quiroga shared on X: "Early-Onset Cancers: Unraveling Biological Causes and Clinical Implications…
Oct 19, 2024, 18:29 | Blog
María Natalia Gandur Quiroga: Cancer-induced systemic pre-conditioning of distant organs
María Natalia Gandur Quiroga, Medical Oncologist and Chief of the Division of Genitourinary Medical Oncology…
Oct 11, 2024, 19:37 | Insight
María Natalia Gandur Quiroga: Mutations and DNA Structures Driving Bladder Cancer
María Natalia Gandur Quiroga recently shared a post on LinkedIn: “Study Uncovers Mutations and DNA…
Oct 3, 2024, 13:00 | Positive
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
September was a significant month dedicated to raising awareness about various cancers, and Prostate Cancer…
Oct 3, 2024, 05:51 | Blog
María Natalia Gandur Quiroga: Muscle-Invasive Bladder Cancer in Non-Curative Patients
María Natalia Gandur Quiroga posted on X about recent paper by Félix Guerrero-Ramos et al.,…
Oct 1, 2024, 09:55 | Blog
María Natalia Gandur Quiroga: Promising Outcomes for Pazopanib Plus Bevacizumab in Clear Cell RCC
María Natalia Gandur Quiroga posted on X: "Promising Outcomes for Pazopanib Plus Bevacizumab in Clear…
Sep 26, 2024, 17:35 | Insight
María Natalia Gandur Quiroga: PRECISE v2 - An updated framework to guide the use of MRI in Prostate Cancer
María Natalia Gandur Quiroga shared a post on LinkedIn about a recent paper by Matthew…
Sep 24, 2024, 13:55 | Blog
María Natalia Gandur Quiroga: The present and future of bispecific antibodies for cancer therapy
María Natalia Gandur Quiroga shared on X: "'The present and future of bispecific antibodies for…
Sep 24, 2024, 10:55 | Blog
Maria Natalia Gandur Quiroga: Whole-body MRI for staging in high-risk prostate cancer
Maria Natalia Gandur Quiroga shared a post on X, about recent paper published in Prostate…
Sep 24, 2024, 09:18 | Blog
María Natalia Gandur Quiroga: Upfront vs. Deferred Cytoreductive Nephrectomy in mRCC
María Natalia Gandur Quiroga posted on X about recent paper by Stepan M. Esagian et…
Sep 23, 2024, 23:48 | Insight
Adjuvant Pembrolizumab in High-Risk Muscle-Invasive Urothelial Carcinoma summary by Maria Natalia Gandur Quiroga
Maria Natalia Gandur Quiroga shared a post on X: "Adjuvant Pembrolizumab in High-Risk Muscle-Invasive Urothelial Carcinoma…
Sep 2, 2024, 08:35 | Insight
Shilpa Gupta: Novel approach of intermittent IO in mRCC
Shilpa Gupta shared a post on X by María Natalia Gandur Quiroga about a recent…
Aug 28, 2024, 18:15 | Insight
Understanding Gleason system evolution for accurate prostrate diagnosis and treatment, summary by María Natalia Gandur Quiroga
María Natalia Gandur Quiroga shared a recent article by Alessandro Crestani on X, adding: "Gleason…
Aug 27, 2024, 23:25 | Insight
Maria Natalia Gandur Quiroga: Key Findings from a Study on Intermediate-Risk Prostate Cancer
Maria Natalia Gandur Quiroga shared on X: “Key Findings from a Study on Intermediate-Risk Prostate…
Aug 1, 2024, 04:07 | Blog
EORTC-1333-GUCG/PEACE III trial has reached it's primary endpoint
María Natalia Gandur Quiroga shared a post on X: "Exciting news from EORTC!  EORTC-1333-GUCG/PEACE III…
Jul 30, 2024, 12:17 | Blog
María Natalia Gandur Quiroga: Highlights from the article 'Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals'
María Natalia Gandur Quiroga posted on LinkedIn about recent paper by Irma Bisceglia et al., titled…
Jul 29, 2024, 23:27 | Insight
María Natalia Gandur Quiroga: Highlights from "The Rise of Supportive Oncology: A Revolution in Cancer Care"
María Natalia Gandur Quiroga shared a post on X about a recent paper titled "The…
Jul 26, 2024, 11:09 | Insight
Long-term Prostate Cancer Mortality Outcomes
María Natalia Gandur Quiroga shared on X about an article titled "Long-term Prostate Cancer–specific Mortality After…
Jul 25, 2024, 07:28 | Insight
María Natalia Gandur Quiroga: Study on Gleason Grade Group 1 Prostate Cancer reveals key findings
María Natalia Gandur Quiroga shared a post on X about a recent paper by Anthony…
Jul 22, 2024, 13:04 | Blog
Study on pRPLND in metastatic non-seminomatous germ cell tumors
María Natalia Gandur Quiroga posted on X about recent paper by Ahmad Mousa et al., commenting:…
Jul 22, 2024, 08:58 | Blog
Tumor-Type Prediction Using Targeted Clinical Genomic Sequencing Data
Maria Natalia Gandur Quiroga shared on X: "Deep-Learning Model for Tumor-Type Prediction Using Targeted Clinical Genomic…
Jul 22, 2024, 08:16 | Blog
Synergistic Effects of PARP Inhibition and Cholesterol Biosynthesis Pathway Modulation
Maria Natalia Gandur Quiroga shared on X: "Key Findings from the Study on Synergistic Effects of…
Jul 11, 2024, 06:37 | Insight
Results of the Complete Review on Targeted Therapies for Advanced Urothelial Carcinoma
María Natalia Gandur Quiroga shared on X: " Results and Main Messages of the Complete…
Jul 10, 2024, 11:57 | Blog
The 2024 Uromigos Cup
Uromigos formed in early 2017 as a group of friends attempting to provide balanced, scientific content…
Jun 25, 2024, 03:54 | Insight
Clinical Validation of the Intermediate-risk Non–muscle-invasive Bladder Cancer Scoring System
Maria Natalia Gandur Quiroga shared on LinkedIn: "Clinical Validation of the Intermediate-risk Non–muscle-invasive Bladder Cancer Scoring…
Jun 24, 2024, 12:08 | Blog
The prognostic value of PSA levels at 7-8 month
Yüksel Ürün shared a post on X:                 …
Jun 6, 2024, 13:18 | Blog
María Natalia Gandur Quiroga on JAVELIN Renal 101 trial by Camillo Porta
María Natalia Gandur Quiroga shared on X/Twitter: ''In It for the Long Run: Updated Outcomes…
May 23, 2024, 06:36 | Insight
María Natalia Gandur Quiroga: New insights on immunotherapy rechallenge in mRCC
María Natalia Gandur Quiroga shared on X: "New insights on immunotherapy rechallenge in mRCC! Key…
Apr 15, 2024, 16:45 | Drugs
NCCN 2024 Prostate Cancer Guidelines Update by Maria Natalia Gandur Quiroga
Maria Natalia Gandur Quiroga shared a post on X: “NCCN 2024 Prostate Cancer Guidelines Update.…
Apr 11, 2024, 06:46 | Opinion
Maria Natalia Gandur Quiroga: The Hallmarks of Precancer
Maria Natalia Gandur Quiroga shared a post on X: "The Hallmarks of Precancer. AACR Journals,…
Apr 11, 2024, 06:39 | Insight
María Natalia Gandur Quiroga: Major updates from EAU24 on prostate cancer screening and diagnosis trials
María Natalia Gandur Quiroga shared on X/Twitter: "Major updates from EAU24 on prostate cancer (PCa) screening…
Mar 29, 2024, 19:30 | Insight
Maria Natalia Gandur Quiroga: New Insights on Bladder Cancer Invasion
Maria Natalia Gandur Quiroga shared on X/Twitter: "New Insights on Bladder Cancer Invasion. Unraveling a…
Mar 8, 2024, 14:46 | Blog
María Natalia Gandur Quiroga: Unveiling New Players in the Tumor Microenvironment: Tumor-Resident Microbes
María Natalia Gandur Quiroga shared a post on LinkedIn: “Unveiling New Players in the Tumor Microenvironment:…
Jan 31, 2024, 15:16 | Blog
María Natalia Gandur Quiroga: As always, Sumanta K. Pal's presentations are a masterclass
María Natalia Gandur Quiroga shared a post on X/Twitter: "Incredible insights from Sumanta K. Pal's…
Jan 26, 2024, 07:33 | Blog
María Natalia Gandur Quiroga: Fantastic article... One of the most anticipated!
María Natalia Gandur Quiroga posted on LinkedIn: "Fantastic article!  One of the most anticipated! New…
Jan 19, 2024, 08:43 | Drugs
María Natalia Gandur Quiroga: A significant advancement in bladder cancer treatment
María Natalia Gandur Quiroga shared on X/Twitter: "The article 'FGFR inhibition augments anti–PD-1 efficacy in…
Jan 18, 2024, 15:12 | Blog
Maria Natalia Gandur Quiroga: Immuno-Oncology Advances in Genitourinary Cancers
Maria Natalia Gandur Quiroga shared a post on LinkedIn: "Immuno-Oncology Advances in Genitourinary Cancers: Introduction:…
Dec 19, 2023, 16:41 | Insight
Maria Natalia Gandur Quiroga: Pioneering Equity in Cancer Treatment: A Model Worth Emulating
Maria Natalia Gandur Quiroga shared on LinkedIn: "Pioneering Equity in Cancer Treatment: A Model Worth…
Nov 27, 2023, 16:21 | Drugs
Maria Natalia Gandur Quiroga: Erdafitinib showcased its potential in a phase 3 trial
Maria Natalia Gandur Quiroga shared on LinkedIn: "Title: Advancements in Urothelial Carcinoma Treatment: Erdafitinib Outshines…
Nov 22, 2023, 03:04 | Drugs
Maria Natalia Gandur Quiroga: Promising results for zanzalintinib in advanced clear cell renal cell carcinoma treatment presented by Sumanta K. Pal
Quoting Maria Natalia Gandur Quiroga on X/Twitter: "Exciting updates from The Kidney Cancer Association's International…
Nov 12, 2023, 17:46 | Blog
María Natalia Gandur Quiroga: Very Proud of great professionals who accompany me every day
María Natalia Gandur Quiroga posted on X/Twitter. "Very Proud of great professionals who accompany me every…
Nov 4, 2023, 00:25 | Insight
María Natalia Gandur Quiroga: After a successful ESMO 23, ADC continues to shine
María Natalia Gandur Quiroga shared a post on X/Twitter: “After a successful ESMO 23, ADC…
Oct 23, 2023, 17:15 | Insight
María Natalia Gandur Quiroga: Disappointing update from ESMO 23: Christina Gratzke reveals KEYNOTE-991 study results.
Quoting María Natalia Gandur Quiroga on X/Twitter: “Disappointing update from ESMO 23: Christina Gratzke reveals KEYNOTE-991…
Oct 12, 2023, 18:13 | Blog
María Natalia Gandur Quiroga: Fantastic review! A pleasure to read: Understanding the Cancer-Immunity Cycle.
Quoting María Natalia Gandur Quiroga on X/Twitter: "Fantastic review! A pleasure to read: Understanding the Cancer-Immunity…
Sep 23, 2023, 18:52 | Blog
María Natalia Gandur Quiroga: Exciting advancements in Synthetic Biology for CAR T cell improvement!
Quoting María Natalia Gandur Quiroga, Chief of the Division of Genitourinary Medical Oncology at the…
Sep 23, 2023, 15:55 | Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 5
A month ago, OncoDaily began its series on '100 Influential Women in Oncology: Key Opinion…
All: 61 Posts: 1 - 100
Special Coverage